The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Obesity Treatment Market Research Report 2025
Synopsis
Obesity is a major health problem worldwide responsible for increased morbidity/mortality and high cost for the society. Management of obesity requires multidisciplinary approaches including diet, food supplement, exercise, behavior change, drug, medical device, gut microbiome manipulation, and surgery. Anti-obesity medical devices are an option for subjects who have not responded to more conservative medical treatments but want an alternative to surgery.
The global Obesity Treatment market was valued at US$ 5452.1 million in 2023 and is anticipated to reach US$ 13530 million by 2030, witnessing a CAGR of 13.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Obesity Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treatment.
Report Scope
The Obesity Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Obesity Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obesity Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
Segment by Type
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Segment by Application
Children
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Obesity Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Obesity is a major health problem worldwide responsible for increased morbidity/mortality and high cost for the society. Management of obesity requires multidisciplinary approaches including diet, food supplement, exercise, behavior change, drug, medical device, gut microbiome manipulation, and surgery. Anti-obesity medical devices are an option for subjects who have not responded to more conservative medical treatments but want an alternative to surgery.
The global Obesity Treatment market was valued at US$ 5452.1 million in 2023 and is anticipated to reach US$ 13530 million by 2030, witnessing a CAGR of 13.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Obesity Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treatment.
Report Scope
The Obesity Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Obesity Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Obesity Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
Segment by Type
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Segment by Application
Children
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Obesity Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgical & Implant Devices
1.2.3 Medication Therapy
1.2.4 Dietary
1.2.5 Other
1.3 Market by Application
1.3.1 Global Obesity Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Obesity Treatment Market Perspective (2019-2030)
2.2 Obesity Treatment Growth Trends by Region
2.2.1 Global Obesity Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Obesity Treatment Historic Market Size by Region (2019-2024)
2.2.3 Obesity Treatment Forecasted Market Size by Region (2025-2030)
2.3 Obesity Treatment Market Dynamics
2.3.1 Obesity Treatment Industry Trends
2.3.2 Obesity Treatment Market Drivers
2.3.3 Obesity Treatment Market Challenges
2.3.4 Obesity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Obesity Treatment Players by Revenue
3.1.1 Global Top Obesity Treatment Players by Revenue (2019-2024)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Obesity Treatment Revenue
3.4 Global Obesity Treatment Market Concentration Ratio
3.4.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2023
3.5 Obesity Treatment Key Players Head office and Area Served
3.6 Key Players Obesity Treatment Product Solution and Service
3.7 Date of Enter into Obesity Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Obesity Treatment Breakdown Data by Type
4.1 Global Obesity Treatment Historic Market Size by Type (2019-2024)
4.2 Global Obesity Treatment Forecasted Market Size by Type (2025-2030)
5 Obesity Treatment Breakdown Data by Application
5.1 Global Obesity Treatment Historic Market Size by Application (2019-2024)
5.2 Global Obesity Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Obesity Treatment Market Size (2019-2030)
6.2 North America Obesity Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Obesity Treatment Market Size by Country (2019-2024)
6.4 North America Obesity Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Obesity Treatment Market Size (2019-2030)
7.2 Europe Obesity Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Obesity Treatment Market Size by Country (2019-2024)
7.4 Europe Obesity Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Obesity Treatment Market Size (2019-2030)
8.2 Asia-Pacific Obesity Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Obesity Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Obesity Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Obesity Treatment Market Size (2019-2030)
9.2 Latin America Obesity Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Obesity Treatment Market Size by Country (2019-2024)
9.4 Latin America Obesity Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Obesity Treatment Market Size (2019-2030)
10.2 Middle East & Africa Obesity Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Obesity Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Obesity Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Detail
11.1.2 NutriSystem, Inc. (U.S.) Business Overview
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
11.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.1.5 NutriSystem, Inc. (U.S.) Recent Development
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Detail
11.2.2 Kellogg Company (U.S.) Business Overview
11.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
11.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.2.5 Kellogg Company (U.S.) Recent Development
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Detail
11.3.2 Ethicon, Inc. (U.S.) Business Overview
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
11.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.3.5 Ethicon, Inc. (U.S.) Recent Development
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Detail
11.4.2 Medtronic (U.S.) Business Overview
11.4.3 Medtronic (U.S.) Obesity Treatment Introduction
11.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.4.5 Medtronic (U.S.) Recent Development
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Detail
11.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
11.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2019-2024)
11.5.5 F. Hoffmann-La Roche (Switzerland) Recent Development
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Detail
11.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
11.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Development
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Detail
11.7.2 Herbalife Ltd. (U.S.) Business Overview
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
11.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.7.5 Herbalife Ltd. (U.S.) Recent Development
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Detail
11.8.2 Covidien plc (U.S.) Business Overview
11.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
11.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.8.5 Covidien plc (U.S.) Recent Development
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Detail
11.9.2 Apollo Endosurgery (U.S.) Business Overview
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
11.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.9.5 Apollo Endosurgery (U.S.) Recent Development
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Detail
11.10.2 Amer Sports (Finland) Business Overview
11.10.3 Amer Sports (Finland) Obesity Treatment Introduction
11.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2019-2024)
11.10.5 Amer Sports (Finland) Recent Development
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Detail
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2019-2024)
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Development
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Detail
11.12.2 Cybex International (U.S.) Business Overview
11.12.3 Cybex International (U.S.) Obesity Treatment Introduction
11.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.12.5 Cybex International (U.S.) Recent Development
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Detail
11.13.2 USGI Medical (U.S.) Business Overview
11.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
11.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.13.5 USGI Medical (U.S.) Recent Development
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Detail
11.14.2 Olympus Corporation (Japan) Business Overview
11.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
11.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2019-2024)
11.14.5 Olympus Corporation (Japan) Recent Development
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Detail
11.15.2 Brunswick Corporation (U.S.) Business Overview
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
11.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2019-2024)
11.15.5 Brunswick Corporation (U.S.) Recent Development
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Detail
11.16.2 Technogym SpA (Italy) Business Overview
11.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
11.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2019-2024)
11.16.5 Technogym SpA (Italy) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Obesity Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgical & Implant Devices
Table 3. Key Players of Medication Therapy
Table 4. Key Players of Dietary
Table 5. Key Players of Other
Table 6. Global Obesity Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Obesity Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Obesity Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Obesity Treatment Market Share by Region (2019-2024)
Table 10. Global Obesity Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Obesity Treatment Market Share by Region (2025-2030)
Table 12. Obesity Treatment Market Trends
Table 13. Obesity Treatment Market Drivers
Table 14. Obesity Treatment Market Challenges
Table 15. Obesity Treatment Market Restraints
Table 16. Global Obesity Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Obesity Treatment Market Share by Players (2019-2024)
Table 18. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2023)
Table 19. Ranking of Global Top Obesity Treatment Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Obesity Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Obesity Treatment Product Solution and Service
Table 23. Date of Enter into Obesity Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Obesity Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Obesity Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Obesity Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Obesity Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Obesity Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Obesity Treatment Revenue Market Share by Application (2019-2024)
Table 31. Global Obesity Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Obesity Treatment Revenue Market Share by Application (2025-2030)
Table 33. North America Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Obesity Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Obesity Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Obesity Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Obesity Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Obesity Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Obesity Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Obesity Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Obesity Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Obesity Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Obesity Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Obesity Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Obesity Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. NutriSystem, Inc. (U.S.) Company Detail
Table 49. NutriSystem, Inc. (U.S.) Business Overview
Table 50. NutriSystem, Inc. (U.S.) Obesity Treatment Product
Table 51. NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 52. NutriSystem, Inc. (U.S.) Recent Development
Table 53. Kellogg Company (U.S.) Company Detail
Table 54. Kellogg Company (U.S.) Business Overview
Table 55. Kellogg Company (U.S.) Obesity Treatment Product
Table 56. Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 57. Kellogg Company (U.S.) Recent Development
Table 58. Ethicon, Inc. (U.S.) Company Detail
Table 59. Ethicon, Inc. (U.S.) Business Overview
Table 60. Ethicon, Inc. (U.S.) Obesity Treatment Product
Table 61. Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 62. Ethicon, Inc. (U.S.) Recent Development
Table 63. Medtronic (U.S.) Company Detail
Table 64. Medtronic (U.S.) Business Overview
Table 65. Medtronic (U.S.) Obesity Treatment Product
Table 66. Medtronic (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 67. Medtronic (U.S.) Recent Development
Table 68. F. Hoffmann-La Roche (Switzerland) Company Detail
Table 69. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 70. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product
Table 71. F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 72. F. Hoffmann-La Roche (Switzerland) Recent Development
Table 73. Atkins Nutritionals, Inc. (U.S.) Company Detail
Table 74. Atkins Nutritionals, Inc. (U.S.) Business Overview
Table 75. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product
Table 76. Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 77. Atkins Nutritionals, Inc. (U.S.) Recent Development
Table 78. Herbalife Ltd. (U.S.) Company Detail
Table 79. Herbalife Ltd. (U.S.) Business Overview
Table 80. Herbalife Ltd. (U.S.) Obesity Treatment Product
Table 81. Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 82. Herbalife Ltd. (U.S.) Recent Development
Table 83. Covidien plc (U.S.) Company Detail
Table 84. Covidien plc (U.S.) Business Overview
Table 85. Covidien plc (U.S.) Obesity Treatment Product
Table 86. Covidien plc (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 87. Covidien plc (U.S.) Recent Development
Table 88. Apollo Endosurgery (U.S.) Company Detail
Table 89. Apollo Endosurgery (U.S.) Business Overview
Table 90. Apollo Endosurgery (U.S.) Obesity Treatment Product
Table 91. Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 92. Apollo Endosurgery (U.S.) Recent Development
Table 93. Amer Sports (Finland) Company Detail
Table 94. Amer Sports (Finland) Business Overview
Table 95. Amer Sports (Finland) Obesity Treatment Product
Table 96. Amer Sports (Finland) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 97. Amer Sports (Finland) Recent Development
Table 98. Johnson Health Technology, Ltd. (Taiwan) Company Detail
Table 99. Johnson Health Technology, Ltd. (Taiwan) Business Overview
Table 100. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product
Table 101. Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 102. Johnson Health Technology, Ltd. (Taiwan) Recent Development
Table 103. Cybex International (U.S.) Company Detail
Table 104. Cybex International (U.S.) Business Overview
Table 105. Cybex International (U.S.) Obesity Treatment Product
Table 106. Cybex International (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 107. Cybex International (U.S.) Recent Development
Table 108. USGI Medical (U.S.) Company Detail
Table 109. USGI Medical (U.S.) Business Overview
Table 110. USGI Medical (U.S.) Obesity Treatment Product
Table 111. USGI Medical (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 112. USGI Medical (U.S.) Recent Development
Table 113. Olympus Corporation (Japan) Company Detail
Table 114. Olympus Corporation (Japan) Business Overview
Table 115. Olympus Corporation (Japan) Obesity Treatment Product
Table 116. Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 117. Olympus Corporation (Japan) Recent Development
Table 118. Brunswick Corporation (U.S.) Company Detail
Table 119. Brunswick Corporation (U.S.) Business Overview
Table 120. Brunswick Corporation (U.S.) Obesity Treatment Product
Table 121. Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 122. Brunswick Corporation (U.S.) Recent Development
Table 123. Technogym SpA (Italy) Company Detail
Table 124. Technogym SpA (Italy) Business Overview
Table 125. Technogym SpA (Italy) Obesity Treatment Product
Table 126. Technogym SpA (Italy) Revenue in Obesity Treatment Business (2019-2024) & (US$ Million)
Table 127. Technogym SpA (Italy) Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obesity Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Obesity Treatment Market Share by Type: 2023 VS 2030
Figure 3. Surgical & Implant Devices Features
Figure 4. Medication Therapy Features
Figure 5. Dietary Features
Figure 6. Other Features
Figure 7. Global Obesity Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Obesity Treatment Market Share by Application: 2023 VS 2030
Figure 9. Children Case Studies
Figure 10. Adults Case Studies
Figure 11. Obesity Treatment Report Years Considered
Figure 12. Global Obesity Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Obesity Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Obesity Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Obesity Treatment Market Share by Players in 2023
Figure 16. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Obesity Treatment Revenue in 2023
Figure 18. North America Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Obesity Treatment Market Share by Country (2019-2030)
Figure 20. United States Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Obesity Treatment Market Share by Country (2019-2030)
Figure 24. Germany Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Obesity Treatment Market Share by Region (2019-2030)
Figure 32. China Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Obesity Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Obesity Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Obesity Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. NutriSystem, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 47. Kellogg Company (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 48. Ethicon, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 49. Medtronic (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 50. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 51. Atkins Nutritionals, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 52. Herbalife Ltd. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 53. Covidien plc (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 54. Apollo Endosurgery (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 55. Amer Sports (Finland) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 56. Johnson Health Technology, Ltd. (Taiwan) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 57. Cybex International (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 58. USGI Medical (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 59. Olympus Corporation (Japan) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 60. Brunswick Corporation (U.S.) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 61. Technogym SpA (Italy) Revenue Growth Rate in Obesity Treatment Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
